Prot# NU 04U1: A Pilot Study of Denileukin Diftitox in Combination with High-Dose IL-2 for Patients with Metastatic Renal Cell Carcinoma

    Project: Research project

    Project Details

    StatusFinished
    Effective start/end date9/3/0411/12/10

    Funding

    • Ligand Pharmaceuticals, Inc. (NU 04U1)